SHISAL2B and neoplasm: We also demonstrated expression of FAM159B in many tumour cell lines and tumour entities, with especially high levels in pituitary adenomas, medullary and anaplastic thyroid carcinomas, parathyroid adenomas, lung and ovarian carcinomas, lymphomas, and neuroendocrine tumours of various origins.